Alexza Pharmaceuticals Inc (ALXA)

0.94
0.01 1.63
Prev Close 0.92
Open 0.92
Day Low/High 0.91 / 0.95
52 Wk Low/High 0.22 / 1.60
Volume 305.73K
Avg Volume 144.20K
Exchange
Shares Outstanding 21.75M
Market Cap 20.01M
EPS -1.10
Div & Yield N.A. (N.A)

Jones Soda, FSI International: Early Volume Plays

Several stocks trading near $5, including Jones Soda, were poised to move on above-average volume during Thursday's session.

14 Biotech Stocks Facing FDA Approval

News of a drug's approval or rejection from the FDA can rock or kill a biotech stock's price. Here are 14 firms facing FDA approval decisions through October.

Stock Offerings: Beazer Homes

Stock Offerings: Beazer Homes

Beazer Homes priced an offering of 12.5 million common shares at $5.81 per share.

14 Biotech Stocks Facing FDA Approval

News of a drug's approval or rejection from the FDA can rock or kill a biotech stock's price. Here are 14 companies with drugs facing FDA approval decisions in 2010.

Alcatel, JA Solar: Early Volume Plays

Alcatel, JA Solar: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Thursday's session.

Athersys, Lionbridge: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.

JA Solar, Array BioPharma: Early Volume Plays

JA Solar, Array BioPharma: Early Volume Plays

Several stocks trading under $5 were poised to move on above-average volume during Tuesday's session.

Biotech Mailbag: Lessons From Clinical Trials

Biotech Mailbag: Lessons From Clinical Trials

Senior Columnist Adam Feuerstein's column on Cell Genesys elicited some compliments -- and some negative mail from Dendreon fans.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Mylan gets FDA approval for its generic zyrtec.

Thursday's Late Winners & Losers

Thursday's Late Winners & Losers

Chordiant inks a big deal with a telecom company.

Wednesday's Health Winners & Losers

Allergan rises on a deal to buy privately held Esprit Pharma.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

OSI Pharma gains on an analyst upgrade.

Real Story: Telecom Insights

Real Story: Telecom Insights

Telecom Connection's Bob Faulkner gives the scoop on Agere's warning and Verizon's deal with Alcatel-Lucent.

Monday's Small-Cap Winners & Losers

Monday's Small-Cap Winners & Losers

Alexza Pharma moves higher on positive trial results for its schizophrenia treatment.

Thursday's Health Winners & Losers

Forest Labs falls on a big buyout.